John Mclaughlin

John Mclaughlin discloses dealings in 2 companies, chiefly Compumed Inc and Sonoma Pharmaceuticals, Inc. We count 31 filings; the first trade dates from 14 June 2007 and the latest from 30 May 2018.

No open-market purchase appears, only 9 sales worth €116k. Outside the open market, there are 13 share grants and 9 option exercises.

The latest filing, published on 1 June 2018, reports a share grant in Sonoma Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.